Neuroimaging and CSF Biomarker Program (Alzheimer’s disease)
The Neuroimaging and CSF Biomarker Program from the Alzheimer´s Drug Discovery Foundation provides funding to support the identification of biomarkers in Alzheimer´s disease. The grant is available to researchers worldwide, at both non-profit research institutions as well as for-profit organizations. Applicants may apply for up to 600,000 USD (direct costs only) for 1 year with the potential for renewal. There are three assessment rounds per year and the next letter of intent is due September 30, 2022 and the full application is due on December 2, 2022.
Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.